Strive’s $27 Warrants Expire Tuesday. Up to $628M Is at Stake.

Strive’s October 5 filing reported traditional warrants covering 23,249,706 common shares as of October 2. At the split-adjusted $27 exercise price, full cash exercise would generate approximately $627.7 million before costs. Subsequent exercises may already have reduced that balance.

Below $27, buying shares outright would be cheaper. Funding, execution costs and applicable ownership limits also affect participation.

The deadline and the cash

CEO Matt Cole has identified 5:00 p.m. Eastern on Tuesday, October 13, or 2:00 p.m. Pacific, as the deadline. Under the warrant form, payment can follow the exercise notice under the settlement terms; every dollar need not arrive Tuesday afternoon.

The proceeds estimates assume cash exercise. The contract permits cashless exercise in specified registration/prospectus circumstances.

One disclosure wrinkle: Nasdaq is open Monday, but EDGAR is closed October 12. A company announcement is possible; an October 12 SEC filing should not be assumed.

Exercises have accelerated

Weekly reductions in warrant shares imply approximately $90.3 million of gross proceeds between September 11 and October 2:

Calculated from the September 21, September 28 and October 5 filings: warrant-share reductions × $27. Assumes those reductions represent cash exercises; the tables do not separately report proceeds.

Could fewer shorts lift ASST?

MarketBeat reports 21.94 million shares short as of September 30, down 8.4% from 23.94 million on September 15. These aggregate figures do not identify warrant holders; how much short interest is warrant-related remains unverified.

The hedge is plausible. A holder could short a share at $30, exercise at $27 and deliver the newly issued share to the lender—a $3 gross spread before warrant cost, borrowing fees and other expenses. Short interest could fall without an open-market purchase.

The sale economically offsets the exercise outlay, but does not automatically fund it: brokers may hold short-sale proceeds as collateral, requiring separate cash or financing.

The potential bullish catalyst is an end to warrant-related selling. Less selling could help the stock, but that is different from shorts buying shares to cover. Unhedged holders could also sell newly exercised shares. Expiry alone does not guarantee a squeeze or rally.

The next scheduled short-interest snapshot is October 15, published October 26. Daily short-sale volume is not outstanding short interest.

What full exercise could buy

At $84,422 per BTC, Strive’s latest disclosed weekly average purchase price, the full $627.7 million could buy approximately 7,436 BTC, lifting holdings from 29,462 to 36,898 BTC.

But effective common shares would also increase by approximately 23%. Strive excludes traditional warrants from both effective common shares and assumed fully diluted shares (AFDS) until exercise.

Each $27 received could buy 31,982 sats at that assumed price, more than either starting per-share balance:

BTCperShare calculations assume all proceeds purchase BTC at $84,422, no additional costs and no other changes to holdings or shares. This historical price is not a live quote or forecast.

With 100% reinvestment, the break-even Bitcoin prices are approximately $92,504 on effective common and $95,048 on AFDS. Above those levels, warrant-funded purchases alone would dilute gross BTC per share relative to the October 2 baseline.

The ASST treasury page tracks both share bases; the accretion calculator lets readers test other scenarios.

Exercise does not guarantee accretion

Even at $84,422 BTC, roughly 91.3% of proceeds must purchase Bitcoin just to preserve effective BTC per share, holding everything else constant.

Strive could retain cash or use capital for its $500 million discretionary SATA repurchase facility. Retiring preferred stock could reduce senior claims and future dividends, but it would not add Bitcoin to offset the newly issued common shares.

That is not necessarily a poor allocation. It is a different benefit, captured more directly by net backing measures such as CEBE than by gross BTC per share.

Warrants that expire unexercised add neither cash nor shares, leaving reported gross BTC per share unchanged while closing a potential funding source. That does not imply a neutral stock-price reaction.

After Tuesday, a shrinking warrant balance will not tell the whole story. Investors need to distinguish exercises from expirations and see how much cash Strive actually received.

Independent analysis, not investment advice. Figures reviewed October 10, 2026; treasury calculations use October 2 balances. Gross BTC per share does not deduct preferred claims or measure stock returns.